Hiroshi Kaneda

559 citations
34 papers · 377 indexed · h-index 10
Topics
Dialysis and Renal Disease Management (8 papers)Uterine Myomas and Treatments (5 papers)Endometriosis Research and Treatment (4 papers)

In The Last Decade

Hiroshi Kaneda

27 papers receiving 362 citations

Peers

Hiroshi Kaneda
Comparison fields: 5 of 71
  • Oncology 114
  • Molecular Biology 97
  • Immunology 91
  • Obstetrics and Gynecology 69
  • Epidemiology 63
Replace Tomoyoshi Inoue with:
Tomoyoshi Inoue Japan
Emel Ebru Pala Türkiye
Masaya Yamato Japan
Roman Zyla Canada
Burcu Barutçuoğlu Türkiye
Friedell Gh United States
Rizk Elbaz Egypt
Christine Azéma France
Hang Pong Ng United States
Hiroshi Kaneda relative to Tomoyoshi Inoue Japan Tomoyoshi Inoue's profile →
Citations per field
00.5×1.5×2.5×
Tomoyoshi Inoue · 1×
Citations per year

Countries citing papers authored by Hiroshi Kaneda

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Kaneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kaneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kaneda more than expected).

Fields of papers citing papers by Hiroshi Kaneda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Kaneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kaneda. The network helps show where Hiroshi Kaneda may publish in the future.

Co-authorship network of co-authors of Hiroshi Kaneda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kaneda. A scholar is included among the top collaborators of Hiroshi Kaneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kaneda. Hiroshi Kaneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 0
5 1
6 6
7 27
8 47
9 5
10 3
11 9
12 71
13 34
14 0
15 4
16 30
17 39
18 33
19 9
20 1

About Hiroshi Kaneda

Hiroshi Kaneda is a scholar working on Nephrology, Obstetrics and Gynecology and Reproductive Medicine, having authored 34 papers that have together received 377 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (8 papers), Uterine Myomas and Treatments (5 papers) and Endometriosis Research and Treatment (4 papers). The work is most often cited by research in Obstetrics and Gynecology (69 citations), Reproductive Medicine (52 citations) and Nephrology (36 citations). Hiroshi Kaneda has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Soshi Kusunoki, Yasuhisa Terao, Satoru Takeda, Tsuyoshi Ota, Shigeru Ono, Saburo Horiuchi, Tetsuya Taga, Kouichi Tabu, Kiyoko Kato and Ko Okumura. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026